H.R. 1425 - 116th Congress (2019-2020) - Patient Protection and Affordable Care Enhancement Act

This bill establishes the Improve Health Insurance Affordability Fund. States must use allocated funds to (1) issue reinsurance payments to health insurers (i.e., reimbursements to protect insurers against exceedingly high claims) for individual health insurance coverage, or (2) provide other assistance to reduce out-of-pocket costs (e.g., copayments, coinsurance, and deductibles) for qualified health plans offered in the individual market.

The Centers for Medicare & Medicaid Services must distribute funding to states in accordance with a specified methodology.

Text (4)

Placed on Calendar Senate

September 8, 2020

Engrossed in House

June 29, 2020

Reported in House

March 9, 2020

Introduced in House

February 28, 2019

Amendments (1)

Jun 29, 2020

Agreed to in House

Sponsorship

House Amendment 819

Pursuant to the provisions of H.Res. 1017 the amendment in the nature of a substitute consisting of the text of Rules Committee Print 116-56, modified by the amendment printed in Part B of House Report 116-436 is adopted.

Agreed To

Actions (26)

Show Only Major Actions

09/08/2020

Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 523.

08/13/2020

Read the first time. Placed on Senate Legislative Calendar under Read the First Time.

06/30/2020

Received in the Senate.

06/29/2020

Motion to reconsider laid on the table Agreed to without objection.

06/29/2020

On passage Passed by the Yeas and Nays: 234 - 179 (Roll no. 124). (text: CR H2599-2614)

06/29/2020

Passed/agreed to in House: On passage Passed by the Yeas and Nays: 234 - 179 (Roll no. 124).

06/29/2020

On motion to recommit with instructions Failed by the Yeas and Nays: 187 - 223 (Roll no. 123).

06/29/2020

Considered as unfinished business. (consideration: CR H2664-2665)

06/29/2020

POSTPONED PROCEEDINGS - At the conclusion of debate on the motion to recommit with instructions, the Chair put the question on the motion and by voice vote, announced that the noes had prevailed. Mr. Walden demanded the yeas and nays and the Chair postponed further consideration on the motion to recommit until a time to be announced.

06/29/2020

The previous question on the motion to recommit with instructions was ordered without objection.

06/29/2020

Floor summary: DEBATE - The House proceeded with 10 minutes of debate on the Walden motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to prevent the bill from taking effect unless the Secretary of Health and Human Services certifies that no provision of the bill would adversely affect research related to any drug intended to treat or prevent the virus that causes COVID-19.

06/29/2020

Mr. Walden moved to recommit with instructions to the Committee on Energy and Commerce. (text: CR H2642-2643)

06/29/2020

The previous question was ordered pursuant to the rule.

06/29/2020

DEBATE - The House proceeded with three hours of debate on H.R. 1425.

06/29/2020

Rule provides for consideration of H.R. 1425, H.R. 5332, H.R. 7120, H.R. 7301 and H.J. Res. 90. The resolution provides that the provisions of section 125(c) of the Uruguay Round Agreements Act shall not apply during the remainder of the 116th Congress and the resolution amends H.Res. 967, agreed to on May 15, 2020.

06/29/2020

Considered under the provisions of rule H. Res. 1017. (consideration: CR H2599-2644)

06/24/2020

Rules Committee Resolution H. Res. 1017 Reported to House. Rule provides for consideration of H.R. 1425, H.R. 5332, H.R. 7120, H.R. 7301 and H.J. Res. 90. The resolution provides that the provisions of section 125(c) of the Uruguay Round Agreements Act shall not apply during the remainder of the 116th Congress and the resolution amends H.Res. 967, agreed to on May 15, 2020.

03/09/2020

Placed on the Union Calendar, Calendar No. 334.

03/09/2020

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-414.

04/04/2019

Ordered to be Reported (Amended) by the Yeas and Nays: 30 - 22.

04/03/2019

Committee Consideration and Mark-up Session Held.

03/27/2019

Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 13 .

03/27/2019

Subcommittee Consideration and Mark-up Session Held.

03/01/2019

Referred to the Subcommittee on Health.

02/28/2019

Referred to the House Committee on Energy and Commerce.

02/28/2019

Introduced in House

Public Record

Record Updated

Nov 1, 2022 5:03:33 PM